These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25558752)

  • 1. [Natriuretic peptide in patients with Chagas disease: diagnostic utility in heart failure].
    Pozo-Pérez A; Jorquera-Fernández A; Rodríguez-Urbaneja F; Romero-Peña L; Geraldino-Carvajal O; Cáceres-Cauro A; Rosas-Martínez M
    Invest Clin; 2014 Dec; 55(4):321-31. PubMed ID: 25558752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of brain natriuretic peptide after acute myocardial infarction.
    Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy.
    Talvani A; Rocha MO; Cogan J; Maewal P; de Lemos J; Ribeiro AL; Teixeira MM
    Mem Inst Oswaldo Cruz; 2004 Oct; 99(6):645-9. PubMed ID: 15558179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of asymptomatic patients with chronic Chagas disease through ambulatory electrocardiogram, echocardiogram and B-Type natriuretic peptide analyses.
    Marques DS; Canesin MF; Barutta Júnior F; Fuganti CJ; Barretto AC
    Arq Bras Cardiol; 2006 Sep; 87(3):336-43. PubMed ID: 17057935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides.
    Moreira Mda C; Wang Y; Heringer-Walther S; Wessel N; Walther T
    Congest Heart Fail; 2009; 15(2):75-81. PubMed ID: 19379453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiogram and B-type natriuretic peptide as screening tools for left ventricular systolic dysfunction in a population-based sample of 75-year-old men and women.
    Hedberg P; Lönnberg I; Jonason T; Nilsson G; Pehrsson K; Ringqvist I
    Am Heart J; 2004 Sep; 148(3):524-9. PubMed ID: 15389243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide.
    Kruszewski K; Scott AE; Barclay JL; Small GR; Croal BL; Møller JE; Oh JK; Hillis GS
    Am Heart J; 2010 Jan; 159(1):47-54. PubMed ID: 20102866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction.
    Ishigaki T; Yoshida T; Izumi H; Fujisawa Y; Shimizu S; Masuda K; Asanuma T; Okabe H; Nakatani S
    Echocardiography; 2015 Apr; 32(4):623-9. PubMed ID: 25115860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal-probrain natriuretic peptide and echocardiography in patients with systolic heart failure.
    Al-Meslmani BM; Fahoum SK; Shamia MG
    Saudi Med J; 2005 Nov; 26(11):1695-8. PubMed ID: 16311650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF.
    Takami Y; Horio T; Iwashima Y; Takiuchi S; Kamide K; Yoshihara F; Nakamura S; Nakahama H; Inenaga T; Kangawa K; Kawano Y
    Am J Kidney Dis; 2004 Sep; 44(3):420-8. PubMed ID: 15332214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography.
    Aspromonte N; Feola M; Scardovi AB; Coletta C; D'Eri A; Giovinazzo P; Carunchio A; Chiera A; Fanelli R; Di Giacomo T; Ricci R; Ceci V; Milani L; Valle R
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):406-13. PubMed ID: 16721202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma B-type natriuretic peptide concentration in beta-thalassaemia patients.
    Aessopos A; Farmakis D; Polonifi A; Tsironi M; Fragodimitri C; Hatziliami A; Karagiorga M; Diamanti-Kandarakis E
    Eur J Heart Fail; 2007 May; 9(5):537-41. PubMed ID: 17300987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of B-type natriuretic peptide for assessment of left ventricular function in patients with chronic kidney disease.
    Soleimani A; Nasiri O; Nikoueinejad H; Mianehsaz E; Yousefzade M; Foroozanfard F; Tabatabaizadeh M; Moraveji SA; Rajali M
    Iran J Kidney Dis; 2011 Jul; 5(4):242-7. PubMed ID: 21725181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle.
    Barbosa MM; Nunes Mdo C; Ribeiro AL; Barral MM; Rocha MO
    Eur J Echocardiogr; 2007 Jun; 8(3):204-12. PubMed ID: 16651029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.